NMTRX
Price
$9.91
Change
+$0.01 (+0.10%)
Updated
Sep 9 closing price
Net Assets
1.51B
WFCMX
Price
$11.10
Change
+$0.02 (+0.18%)
Updated
Sep 9 closing price
Net Assets
794.42M
Interact to see
Advertisement

NMTRX vs WFCMX

Header iconNMTRX vs WFCMX Comparison
Open Charts NMTRX vs WFCMXBanner chart's image
Nuveen Municipal Total Return Mgd Accts
Price$9.91
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets1.51B
Allspring Managed Acct CoreBuilder® M
Price$11.10
Change+$0.02 (+0.18%)
VolumeN/A
Net Assets794.42M
NMTRX vs WFCMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NMTRX vs. WFCMX commentary
Sep 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMTRX is a Hold and WFCMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NMTRX has more cash in the bank: 1.51B vs. WFCMX (794M). NMTRX pays higher dividends than WFCMX: NMTRX (4.48) vs WFCMX (4.11). NMTRX was incepted earlier than WFCMX: NMTRX (18 years) vs WFCMX (17 years). NMTRX (0.07) is less costly to investors than WFCMX (0.05). NMTRX is a more actively managed with annual turnover of: 43.00 vs. WFCMX (9.00). NMTRX (0) and WFCMX (0) have matching initial minimum investment requirements. WFCMX annual gain was more profitable for investors over the last year : 1.39 vs. NMTRX (0.52). WFCMX return over 5 years is better than : 5.44 vs. NMTRX (1.48).
NMTRXWFCMXNMTRX / WFCMX
Total Expense Ratio0.000.00-
Annual Report Gross Expense Ratio0.070.05140%
Fund Existence18 years17 years-
Gain YTD0.6731.39348%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.51B794M190%
Annual Yield % from dividends4.484.11109%
Returns for 1 year0.521.3937%
Returns for 3 years9.9612.0982%
Returns for 5 years1.485.4427%
Returns for 10 years29.0021.61134%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNTX0.850.02
+2.93%
Context Therapeutics
KTOS64.560.42
+0.65%
Kratos Defense & Security Solutions
HP20.02-0.02
-0.10%
Helmerich & Payne
RDHL1.42-0.02
-1.39%
Redhill Biopharma Ltd
LE14.19-0.28
-1.94%
Lands' End